Known targets — ChEMBL curated mechanism
ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO
The experimentally established mechanism targets of Water. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN2A known ✓ | Q12879 | 4/20 | 0.41 |
| ▸ | SIGMAR1 known ✓ | Q99720 | 1/20 | 0.41 |
| ▸ | THRB known ✓ | P10828 | 1/20 | 0.39 |
| ▸ | ESR1 known ✓ | P03372 | 1/20 | 0.32 |
| ▸ | ADRB3 known ✓ | P13945 | 1/20 | 0.32 |
| ▸ | ACHE known ✓ | P22303 | 1/20 | 0.32 |
| ▸ | OPRK1 known ✓ | P41145 | 1/20 | 0.32 |
| ▸ | GRIN2D | O15399 | 4/20 | 0.41 |
| ▸ | GRIN3B | O60391 | 4/20 | 0.41 |
| ▸ | GRIN1 | Q05586 | 4/20 | 0.41 |
| ▸ | GRIN2B | Q13224 | 4/20 | 0.41 |
| ▸ | GRIN2C | Q14957 | 4/20 | 0.41 |
| ▸ | GRIN3A | Q8TCU5 | 4/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | SLC22A2 | O15244 | 2/20 | 0.41 |
| ▸ | SLC47A1 | Q96FL8 | 2/20 | 0.41 |
| ▸ | SLC22A1 | O15245 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.41 |
| ▸ | STAT6 | P42226 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1229981 | 0.97 | GRIN2D (0.43) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| Fluoride SCHEMBL28735708 | 0.94 | GRIN2D (0.41) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| Bromide SCHEMBL28339008 | 0.94 | GRIN2D (0.41) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| Hydrochloric Acid SCHEMBL28735705 | 0.94 | LMNA (0.46) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| Iodide SCHEMBL7068204 | 0.94 | GRIN2D (0.41) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL6854205 | 0.84 | GRIN2D (0.38) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| Sulfuric Acid SCHEMBL15345274 | 0.84 | GRIN2D (0.33) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL15345289 | 0.80 | THRB (0.38) | TSHRPOLBTHRB | |
| Water SCHEMBL343274 | 0.77 | GRIN2D (0.36) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL1229980 | 0.74 | GRIN2D (0.38) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 261 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3995449-B1 | METHOD OF PREPARING SCR CATALYST | HYUNDAI MOTOR CO LTD (KR) | 2026-05-06 | — | — | EP | claimed |
| US-20250114779-A1 | A METHOD OF MAKING A CATALYTIC COMPOSITION | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2025-04-10 | — | — | US | claimed |
| CN-114433200-B | SCR catalyst and preparation method thereof | 现代自动车株式会社 | 2025-02-25 | — | — | CN | claimed |
| EP-4377006-A1 | A METHOD OF MAKING A CATALYTIC COMPOSITION | Johnson Matthey Public Limited Company (GB) | 2024-06-05 | — | — | EP | claimed |
| US-20240157310-A1 | PROCESS FOR REMOVING CARBON DIOXIDE FROM ACETYLENE USING CHA-TYPE ZEOLITE MEMBRANE | CLEVELAND STATE UNIVERSITY (US) | 2024-05-16 | — | — | US | claimed |
| US-11964242-B2 | Zeolite membranes, molecular separation methods, and manufacturing processes for zeolite membranes | GEORGIA TECH RESEARCH CORPORATION (US) | 2024-04-23 | — | — | US | claimed |
| CN-115947349-A | Heteroatom beta molecular sieve for low-carbon aldehyde aldol condensation and preparation method thereof | 天津大学 | 2023-04-11 | — | — | CN | claimed |
| CN-112705252-B | Liquid-phase alkylation catalyst, preparation method and application thereof, and method for carrying out liquid-phase alkylation reaction on benzene and ethylene | 中国石油化工股份有限公司 | 2023-04-07 | — | — | CN | claimed |
| WO-2023007113-A1 | A METHOD OF MAKING A CATALYTIC COMPOSITION | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2023-02-02 | — | — | WO | claimed |
| CN-112645344-B | Method for preparing SSZ-13 molecular sieve membrane by steam-assisted conversion | 南京工业大学 | 2023-01-24 | — | — | CN | claimed |
| EP-3670451-A1 | METHOD FOR PRODUCING ZEOLITE HAVING CONTROLLED ALUMINUM CONTENT BY ADJUSTING COMPOSITION OF SYNTHESIS MOTHER LIQUOR | Industry Foundation of Chonnam National University (KR) | 2020-06-24 | — | — | EP | claimed |
| CN-111032571-A | Process for the manufacture of zeolites with controlled aluminium content by adjusting the composition of the synthesis mother liquor | 全南大学校产学协力团 | 2020-04-17 | — | — | CN | claimed |
| CN-110950356-A | Preparation method of CHA type molecular sieve | 吉林大学 | 2020-04-03 | — | — | CN | claimed |
| CN-108579449-B | Method for rapidly synthesizing high-silicon SSZ-13 molecular sieve membrane | 南京工业大学 | 2019-12-17 | — | — | CN | claimed |
| CN-110104658-A | A kind of method directly synthesizing not the Cu-SSZ-13 molecular sieve and its catalyst of alkali metal containing | 无锡威孚环保催化剂有限公司 | 2019-08-09 | — | — | CN | claimed |
| CN-108862307-A | A kind of synthetic method of SSZ-13/MOR eutectic molecular sieve | 无锡威孚环保催化剂有限公司 | 2018-11-23 | — | — | CN | claimed |
| US-9932318-B2 | Catalyst performance in propylene epoxidation | LYONDELL CHEMICAL TECHNOLOGY, L.P. (US) | 2018-04-03 | — | — | US | claimed |
| EP-3283468-A1 | IMPROVED CATALYST PERFORMANCE IN PROPYLENE EPOXIDATION | Lyondell Chemical Technology, L.P. (US) | 2018-02-21 | — | — | EP | claimed |
| US-20160297782-A1 | CATALYST PERFORMANCE IN PROPYLENE EPOXIDATION | LYONDELL CHEMICAL TECHNOLOGY, L.P. (US) | 2016-10-13 | — | — | US | claimed |
| WO-2016164585-A1 | IMPROVED CATALYST PERFORMANCE IN PROPYLENE EPOXIDATION | LYONDELL CHEMICAL TECHNOLOGY, L.P. (US) | 2016-10-13 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160297782-A1 | CATALYST PERFORMANCE IN PROPYLENE EPOXIDATION | AOC2, AOC3, AOX1 | GRIN2A 4121/4885SIGMAR1 926/4885THRB 2519/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.